Events

Alerta De Seguridad para Abbott VP2000 Processor Technical Name: In Vitro Diagnostic Specimen Preparation Equipment ANVISA Registration Number: 80146509035 Hazard Class: I Affected Model: Not Applicable Series Affected: 36001

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por Abbott Laboratórios do Brasil; Abbott Molecular Inc..

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    2294
  • Fecha
    2017-05-22
  • País del evento
    Brazil
  • Fuente del evento
    ANVISA
  • URL de la fuente del evento
    http://www.anvisa.gov.br/sistec/alerta/consultaralerta.asp
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    An Abbott Molecular representative will contact you to schedule a visit to replace the Heating Module Control Board of your VP2000 instrument. If you receive an error message indicating a communication failure between the Heating Module Control Board and the VP2000 computer or have a problem with your VP2000 instrument, contact your local Abbott Molecular Technical Support representative. If no fault occurs, you can continue to operate the instrument under normal operating conditions. Review this statement with your lab manager and staff and keep a copy for future reference. If you have any questions regarding this announcement, please contact Abbott Molecular. We apologize for any inconvenience caused. #### Update of the field action: UPDATED ON 09/27/2017, the company presented the report of completion of the field action, with sending of necessary evidences and corrective actions.
  • Causa
    Abbott molecular has identified a potential for premature failure of the vp2000 heating module due to incorrect voltage rating on an oscillator within the heating module control board. the oscillator is an electrical component used to communicate between the heating module and the vp2000 computer.
  • Acción
    Field Action Code FA-AM-APR2017-219 triggered under the responsibility of ABBOTT LABORATORIES DO BRASIL LTDA. Company will make correction in the field.

Device

Abbott VP2000 Processor Technical Name: In Vitro Diagnostic Specimen Preparation Equipment ANVISA...

Manufacturer

Abbott Laboratórios do Brasil; Abbott Molecular Inc.
  • Empresa matriz del fabricante (2017)
    Abbott Laboratories
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    ANVSANVISA